Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126487) titled 'Multidimensional Advantages of Integrated Traditional Chinese and Western Medicine in the Treatment of Hyperuricemia: A Prospective Cohort Study' on June 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Condition:
Hyperuricemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-09
Target Sample Size: The observation group of hyperuricemia:1074;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...